Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lingxiang Tablets
- Development stage
- Unknown
- Lead developer
- Zhejiang Jolly Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lingxiang Tablets (灵香片) is a Class 1.1 new Traditional Chinese Medicine (TCM) developed by Zhejiang Zolix Pharmaceutical Co., Ltd. It is specifically formulated for the treatment of chronic pelvic pain associated with the sequelae of pelvic inflammatory disease, particularly in patients diagnosed with the 'Kidney Deficiency and Blood Stasis' syndrome according to TCM principles. As a Class 1.1 new drug, it is derived from a clinical experience prescription and is intended to provide a standardized therapeutic option for chronic inflammatory pain in the pelvic region. The drug is currently undergoing Phase II clinical trials in China to evaluate its efficacy and safety in alleviating pain and improving the quality of life for affected patients.
- Brand names
- Lingxiang Tablets
- Other names
- Lingxiang Pian灵香片
Beyond the preview
Go deeper on Lingxiang Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lingxiang Tablets.